Nanalysis Scientific Corp. to Present at the 2024 Cantech Letter Conference in Toronto, ON
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF), a leader in portable NMR machines and MRI technology for industrial and research applications, has announced its participation in the upcoming Cantech Letter Investment Conference on October 9, 2024 in Toronto, Ontario. Sean Krakiwsky, the company's CEO, will deliver an investor presentation and engage in one-on-one meetings with investors during the event.
The conference will take place at the Arcadian Loft, 8th floor, 401 Bay Street, Toronto, ON. Interested parties can register by contacting tara@cantechletter.com. Krakiwsky expressed enthusiasm about the opportunity, stating that the conference provides an excellent platform to strengthen connections within the capital markets, enhance visibility, showcase achievements, and increase the company's profile among investor communities.
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF), un leader nelle macchine NMR portatili e nella tecnologia MRI per applicazioni industriali e di ricerca, ha annunciato la sua partecipazione alla prossima Cantech Letter Investment Conference che si terrà il 9 ottobre 2024 a Toronto, Ontario. Sean Krakiwsky, CEO dell'azienda, presenterà agli investitori e parteciperà a incontri individuali con gli investitori durante l'evento.
La conferenza si svolgerà presso l'Arcadian Loft, 8° piano, 401 Bay Street, Toronto, ON. Le parti interessate possono registrarsi contattando tara@cantechletter.com. Krakiwsky ha espresso entusiasmo per questa opportunità, affermando che la conferenza offre un'eccellente piattaforma per rafforzare le connessioni nei mercati di capitale, migliorare la visibilità, presentare risultati e aumentare il profilo dell'azienda tra le comunità di investitori.
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF), un líder en máquinas NMR portátiles y tecnología MRI para aplicaciones industriales y de investigación, ha anunciado su participación en la próxima Cantech Letter Investment Conference que se llevará a cabo el 9 de octubre de 2024 en Toronto, Ontario. Sean Krakiwsky, el CEO de la compañía, realizará una presentación para inversores y participará en reuniones individuales con inversores durante el evento.
La conferencia se celebrará en Arcadian Loft, 8° piso, 401 Bay Street, Toronto, ON. Los interesados pueden registrarse enviando un correo a tara@cantechletter.com. Krakiwsky expresó su entusiasmo por la oportunidad, afirmando que la conferencia proporciona una excelente plataforma para fortalecer conexiones dentro de los mercados de capital, aumentar la visibilidad, mostrar logros y mejorar el perfil de la empresa entre las comunidades de inversores.
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF)는 산업 및 연구 응용을 위한 휴대용 NMR 기계와 MRI 기술의 선두주자로, 2024년 10월 9일에 온타리오주 토론토에서 열리는 Cantech Letter Investment Conference에 참가한다고 발표했습니다. Sean Krakiwsky CEO가 투자자 발표를 하고 행사 동안 투자자들과 일대일 미팅을 가질 예정입니다.
회의는 Arcadian Loft, 8층, 401 Bay Street, Toronto, ON에서 열립니다. 관심 있는 분들은 tara@cantechletter.com으로 등록할 수 있습니다. Krakiwsky는 이 기회에 대한 열정을 표현하며, 회의가 자본 시장 내 연결을 강화하고 가시성을 높이며 성과를 보여주고 투자자 커뮤니티 사이에서 회사의 프로필을 높이는 훌륭한 플랫폼을 제공한다고 말했습니다.
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF), un leader dans les appareils NMR portables et la technologie IRM pour des applications industrielles et de recherche, a annoncé sa participation à la prochaine Cantech Letter Investment Conference qui se tiendra le 9 octobre 2024 à Toronto, Ontario. Sean Krakiwsky, le CEO de l'entreprise, fera une présentation aux investisseurs et participera à des rencontres individuelles avec des investisseurs durant l'événement.
La conférence se déroulera à l'Arcadian Loft, 8e étage, 401 Bay Street, Toronto, ON. Les parties intéressées peuvent s'inscrire en contactant tara@cantechletter.com. Krakiwsky a exprimé son enthousiasme pour cette opportunité, affirmant que la conférence constitue une excellente plateforme pour renforcer les liens dans les marchés de capitaux, améliorer la visibilité, présenter des réussites et accroître le profil de l'entreprise parmi les communautés d'investisseurs.
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF), ein Führer in tragbaren NMR-Geräten und MRI-Technologie für industrielle und Forschungsanwendungen, hat seine Teilnahme an der bevorstehenden Cantech Letter Investment Conference am 9. Oktober 2024 in Toronto, Ontario, angekündigt. Sean Krakiwsky, der CEO des Unternehmens, wird eine Präsentation für Investoren halten und während der Veranstaltung Einzelgespräche mit Investoren führen.
Die Konferenz findet im Arcadian Loft, 8. Etage, 401 Bay Street, Toronto, ON statt. Interessierte Parteien können sich registrieren, indem sie tara@cantechletter.com kontaktieren. Krakiwsky äußerte seine Begeisterung über die Gelegenheit und erklärte, dass die Konferenz eine ausgezeichnete Plattform bietet, um Verbindungen in den Kapitalmärkten zu stärken, die Sichtbarkeit zu erhöhen, Erfolge zu präsentieren und das Profil des Unternehmens unter den Investoren zu steigern.
- None.
- None.
Calgary, Alberta--(Newsfile Corp. - October 3, 2024) - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF), a leader in portable NMR machines and MRI technology for industrial and research applications, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9, 2024 in Toronto Ontario. Sean Krakiwsky, Chief Executive Officer of Nanalysis Scientific Corp. will be doing an investor presentation and participating in 1-on-1 meetings with investors at the conference.
2024 Cantech Letter Conference
Date: Wednesday, October 9, 2024
Location: Arcadian Loft, 8th floor, 401 Bay Street, Toronto, ON
Contact: tara@cantechletter.com to register
More info: https://www.cantechletter.com/conference/
Sean Krakiwsky , Chief Executive Officer of Nanalysis Scientific Corp. commented, “We are delighted to be participating in the Cantech Letter Conference as it’s an excellent platform to strengthen our connections within the capital markets. We hope to enhance our visibility, showcase our achievements, and increase our profile among the investor communities.”
About Cantech Letter Conference
The Cantech Letter Conference, recognized as Canada’s foremost technology investment event, provides up and coming technology companies with the unique opportunity to showcase their innovations and growth strategies, and participate in individual 1-on-1 meetings with potential investors and capital markets professionals. The conference serves as a hub for networking, knowledge exchange, and investment opportunities, while also featuring panel discussions with industry experts to offer insights into current trends, challenges, and opportunities within the technology sector.
About Nanalysis Scientific Corp.
About Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FSE: 1N1)Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms
For additional Information, please contact:
Matthew Selinger, Investor Relations
4155728152
matthew.selinger@nanalysis.com
FAQ
When and where is Nanalysis Scientific Corp. (NSCIF) presenting at the Cantech Letter Conference?
Who will be representing Nanalysis Scientific Corp. (NSCIF) at the 2024 Cantech Letter Conference?
What activities will Nanalysis Scientific Corp. (NSCIF) participate in at the Cantech Letter Conference?
How can investors register for the 2024 Cantech Letter Conference where Nanalysis Scientific Corp. (NSCIF) is presenting?
What is the main goal of Nanalysis Scientific Corp. (NSCIF) in participating in the Cantech Letter Conference?
